Financial News Search | Sharemaestro Newsreel

17:40 22 Jul 2026

TipRanks Earnings Main company 🇺🇸 United States

Verastem Inc (VSTM) Q1 2026 Earnings Report - Results, Call & Slides

Verastem Inc. (VSTM) reported its Q1 2026 earnings, beating EPS estimates but missing on revenue. The company posted an actual EPS of -$0.37 against a consensus of -$0.47, with revenue of $18.67M versus an expected $21.43M. Key highlights include steady product revenue growth from …

VSTM main company

Sharemaestro market context Price above Trend Line 52 weeks -27.5%

15:10 22 Jul 2026

Morningstar Regulatory and legal Main company 🇺🇸 United States

ERAS Deadline Alert: Levi & Korsinsky Reminds Erasca, Inc. (ERAS) Investors of Securities Class Action Deadline on August 10, 2026

Levi & Korsinsky, LLP has filed a securities class action lawsuit against Erasca, Inc. (NASDAQ: ERAS) on behalf of investors who purchased common stock between January 14, 2025, and April 26, 2026. The lawsuit alleges that Erasca concealed patent infringement risks and a patient …

ERAS main company

Sharemaestro market context Trend signal active 52 weeks +1048.8% · Next-week setup positive 63.8%

08:41 22 Jul 2026

Sahm Regulatory and legal Main company 🇺🇸 United States

ERAS INVESTOR DEADLINE: Erasca, Inc. (ERAS) Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit - HBSS

Hagens Berman is investigating a class action lawsuit against Erasca, Inc. (ERAS) for alleged securities law violations. The lawsuit claims that Erasca and its senior executives misled investors about its lead oncology candidate, ERAS-0015, regarding its competitive advantage, safety, and intellectual property moat. Investors …

ERAS main company

Sharemaestro market context Trend signal active 52 weeks +1048.8% · Next-week setup positive 63.8%

04:39 22 Jul 2026

STAT Analyst action Main company 🇺🇸 United States

Redefining how KRAS G12D is targeted in cancer treatment

Verastem Oncology is pioneering a new approach to target the KRAS G12D mutation, which is prevalent in many cancers and traditionally difficult to treat. Their investigational drug, VS-7375, is a dual ON/OFF KRAS G12D inhibitor designed for durable pathway control, showing early anti-tumor activity …

VSTM main company

Sharemaestro market context Price above Trend Line 52 weeks -27.5%

22:41 21 Jul 2026

Investing.com Nigeria Market update Main company 🇺🇸 United States

Jerash Holdings nominates Ringo Ng as board chairman By Investing.com

Jerash Holdings (US), Inc. announced the nomination of Ringo Ng as Chairman of the Board, to be elected at the company’s 2026 Annual Meeting in September. If elected, he will succeed Sam Choi, who will remain CEO but will not seek re-election to the …

JRSH main company

Sharemaestro market context Trend signal active 52 weeks +64.9%

21:09 21 Jul 2026

Stock Titan Market update Main company 🇺🇸 United States

Erasca (ERAS): Erasca Foundation files to sell 8,333 donated shares

The Erasca Foundation has filed a Form 144 notice to sell 8,333 shares of Erasca, Inc. common stock (ERAS) through Merrill Lynch, valued at $157,637.52, with the sale expected on July 21, 2026. This intended sale follows previous sales of 8,333 shares each in …

ERAS main company

Sharemaestro market context Trend signal active 52 weeks +1048.8% · Next-week setup positive 63.8%

15:41 21 Jul 2026

GlobeNewswire Regulatory and legal Main company 🇺🇸 United States

Portnoy Law Firm Announces Class Action on Behalf of Erasca, Inc. Investors

The Portnoy Law Firm has announced a class action lawsuit against Erasca, Inc. on behalf of investors who purchased securities between January 14, 2025, and April 26, 2026. The lawsuit alleges that Erasca and its executives failed to disclose material information regarding the ERAS-0015 …

ERAS main company

Sharemaestro market context Trend signal active 52 weeks +1048.8% · Next-week setup positive 63.8%

14:49 21 Jul 2026

globenewswire.com Market update Main company 🇺🇸 United States

ERAS UPCOMING DEADLINE: SueWallSt Alerts Erasca, Inc. Stockholders of Securities Class Action

NEW YORK, July 21, 2026 (GLOBE NEWSWIRE) -- SueWallSt notifies investors in Erasca, Inc. (NASDAQ: ERAS) that a class action has been filed on behalf of investors who purchased ERAS stock between January 14, 2025 and April 26, 2026. Find out if you could …

ERAS main company

Sharemaestro market context Trend signal active 52 weeks +1048.8% · Next-week setup positive 63.8%

13:11 21 Jul 2026

Stock Titan Market update Main company 🇺🇸 United States

Jerash Co-Founder Could Become Chair as Choi Continues as CEO

Jerash Holdings (NASDAQ: JRSH) announced a planned board leadership transition where co-founder Tsze Lun (Ringo) Ng is nominated to become Chairman, succeeding current Chairman Lin Hung (Sam) Choi. Choi will continue as CEO but will not seek re-election to the board, a move intended …

JRSH main company

Sharemaestro market context Trend signal active 52 weeks +64.9%

13:11 21 Jul 2026

Market source Market update Main company 🇺🇸 United States

Jerash Holdings Announces Board Leadership Transition, Nominates Co-Founder Tsze Lun (Ringo) Ng as Chairman; Lin Hung (Sam) Choi to Continue as CEO

Jerash Holdings (US), Inc. announced a board leadership transition, nominating co-founder Tsze Lun (Ringo) Ng as Chairman. Ringo Ng, who has over 50 years of experience in the garment industry, is expected to be elected at the 2026 Annual Meeting, succeeding Sam Choi. Sam …

JRSH main company

Sharemaestro market context Trend signal active 52 weeks +64.9%

13:11 21 Jul 2026

Stock Titan Market update Main company 🇺🇸 United States

Jerash Holdings (Nasdaq: JRSH) to separate chairman and CEO roles

Jerash Holdings (JRSH) announced a board leadership transition, separating the roles of Chairman and CEO. Sam Choi will step down as Chairman but continue as CEO, President, and Treasurer. Co-founder Ringo (Tsze Lun) Ng has been nominated to succeed Choi as Chairman, effective after …

JRSH main company

Sharemaestro market context Trend signal active 52 weeks +64.9%

11:41 21 Jul 2026

GuruFocus Analyst action Main company 🇺🇸 United States

ERAS Maintained by Morgan Stanley -- Price Target Raised to $21

Morgan Stanley has maintained an "Equal-Weight" rating on Erasca (ERAS) but significantly raised its price target from $12.00 to $21.00, a 75% increase. This reflects growing confidence in Erasca's future despite a GF Score™ of 22/100, which indicates below-average performance potential, particularly due to …

ERAS main company

Sharemaestro market context Trend signal active 52 weeks +1048.8% · Next-week setup positive 63.8%

18:53 20 Jul 2026

GlobeNewswire Regulatory and legal Main company 🇺🇸 United States

ERAS Investors Have Opportunity to Lead Erasca, Inc. Securities Fraud Lawsuit with the Schall Law Firm

The Schall Law Firm is encouraging investors of Erasca, Inc. to join a class action lawsuit alleging securities fraud. The lawsuit claims Erasca made false statements regarding its preclinical data for ERAS-0015, which was based on an improper comparison and risked patent violations. Investors …

ERAS main company

Sharemaestro market context Trend signal active 52 weeks +1048.8% · Next-week setup positive 63.8%

16:11 20 Jul 2026

TMX Newsfile Regulatory and legal Main company 🇺🇸 United States

Kaplan Fox Encourages Investors of Erasca, Inc. (ERAS) Who Suffered Losses to Contact the Firm Before August 10, 2026

Kaplan Fox & Kilsheimer LLP has filed a class action lawsuit against Erasca, Inc. (ERAS) on behalf of investors who purchased securities between January 14, 2025, and April 26, 2026. The lawsuit alleges that Erasca made false and misleading statements regarding its ERAS-0015 drug, …

ERAS main company

Sharemaestro market context Trend signal active 52 weeks +1048.8% · Next-week setup positive 63.8%

15:11 20 Jul 2026

GlobeNewswire Regulatory and legal Main company 🇺🇸 United States

ERAS Shareholder Alert: Erasca, Inc. Securities Class Action Lawsuit - Investors Should Contact Levi & Korsinsky

Levi & Korsinsky, LLP has issued a shareholder alert for investors in Erasca, Inc. (NASDAQ: ERAS) regarding a securities class action lawsuit. The lawsuit alleges that Erasca concealed a patient death and presented misleading cross-study comparisons for its ERAS-0015 Phase 1 trial, leading to …

ERAS main company

Sharemaestro market context Trend signal active 52 weeks +1048.8% · Next-week setup positive 63.8%

04:10 20 Jul 2026

ACCESS Newswire Regulatory and legal Main company 🇺🇸 United States

ERAS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Erasca, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit!

Bronstein, Gewirtz & Grossman, LLC has announced a class action lawsuit against Erasca, Inc. (NASDAQ:ERAS) for alleged violations of federal securities laws. The lawsuit, filed on behalf of investors who purchased Erasca securities between January 14, 2025, and April 26, 2026, claims that Erasca …

ERAS main company

Sharemaestro market context Trend signal active 52 weeks +1048.8% · Next-week setup positive 63.8%

20:10 19 Jul 2026

The National Law Review Regulatory and legal Main company 🇺🇸 United States

Securities Fraud Investigation Into Erasca, Inc. (ERAS) Announced

Glancy Prongay Wolke & Rotter LLP has launched a securities fraud investigation into Erasca, Inc. (ERAS) following significant stock price drops. The investigation stems from allegations by Revolution Medicines, Inc. claiming patent infringement and trade secret misappropriation regarding Erasca’s drug candidate, ERAS-0015. Further investor …

ERAS main company

Sharemaestro market context Trend signal active 52 weeks +1048.8% · Next-week setup positive 63.8%

00:56 19 Jul 2026

globenewswire.com Regulatory and legal Main company 🇺🇸 United States

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Erasca, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ERAS

NEW YORK, July 18, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Erasca, Inc. (NASDAQ: ERAS) between January 14, 2025 and April 26, 2026, inclusive (the “Class Period”), of the important August …

ERAS main company

Sharemaestro market context Trend signal active 52 weeks +1048.8% · Next-week setup positive 63.8%

12:39 18 Jul 2026

WBOC TV Regulatory and legal Main company 🇺🇸 United States

Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Erasca, Inc. (ERAS), Nano-X Imaging Ltd. (NNOX), and Peabody Energy Corporation (BTU) Announced by Holzer & Holzer, LLC

Holzer & Holzer, LLC reminds investors of upcoming lead plaintiff deadlines in class action lawsuits against Erasca, Inc. (ERAS), Nano-X Imaging Ltd. (NNOX), and Peabody Energy Corporation (BTU). Investors who suffered losses after purchasing shares during specified periods for each company are encouraged to …

ERAS main company

Sharemaestro market context Trend signal active 52 weeks +1048.8% · Next-week setup positive 63.8%

21:11 17 Jul 2026

TMX Newsfile Regulatory and legal Main company 🇺🇸 United States

Kaplan Fox Notifies Erasca, Inc. (ERAS) Investors of a Securities Class Action Deadline on August 10, 2026

Kaplan Fox & Kilsheimer LLP has announced a securities class action lawsuit against Erasca, Inc. (ERAS) on behalf of investors who purchased securities between January 14, 2025, and April 26, 2026. The lawsuit stems from allegations that Erasca's ERAS-0015 infringed on a Revolution Medicines, …

ERAS main company

Sharemaestro market context Trend signal active 52 weeks +1048.8% · Next-week setup positive 63.8%

15:09 17 Jul 2026

The AI Journal Regulatory and legal Main company 🇺🇸 United States

Erasca, Inc. Class Action Reminder - Robbins LLP Encourages ERAS Stockholders to Contact the Firm for Information About Their Rights

Robbins LLP is reminding stockholders of Erasca, Inc. (NASDAQ: ERAS) about a class action lawsuit filed on behalf of investors who purchased securities between January 14, 2025, and April 26, 2026. The lawsuit alleges that Erasca failed to disclose that its preclinical data for …

ERAS main company

Sharemaestro market context Trend signal active 52 weeks +1048.8% · Next-week setup positive 63.8%

21:42 16 Jul 2026

The National Law Review Regulatory and legal Main company 🇺🇸 United States

Kaplan Fox Reminds Erasca, Inc. (NASDAQ: ERAS) Investors to Seek a Leadership Role Before Deadline on August 10, 2026

Kaplan Fox & Kilsheimer LLP has filed a class action lawsuit against Erasca, Inc. (NASDAQ: ERAS) on behalf of investors who purchased securities between January 14, 2025, and April 26, 2026. The lawsuit stems from allegations by Revolution Medicines, Inc. that Erasca infringed on …

ERAS main company

Sharemaestro market context Trend signal active 52 weeks +1048.8% · Next-week setup positive 63.8%

18:56 16 Jul 2026

Morningstar Regulatory and legal Main company 🇺🇸 United States

ERAS INVESTOR DEADLINE: Erasca, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit - HBSS

Robbins Geller Rudman & Dowd LLP announces that investors who purchased Erasca, Inc. (NASDAQ: ERAS) common stock between January 14, 2025, and April 26, 2026, have until August 10, 2026, to seek appointment as lead plaintiff in a class action lawsuit. The lawsuit alleges …

ERAS main company

Sharemaestro market context Trend signal active 52 weeks +1048.8% · Next-week setup positive 63.8%

14:41 16 Jul 2026

GlobeNewswire Regulatory and legal Main company 🇺🇸 United States

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Erasca, Inc. (ERAS)

Bernstein Liebhard LLP has announced a securities fraud class action lawsuit against Erasca, Inc. (NASDAQ: ERAS) on behalf of investors who purchased shares between January 14, 2025, and April 26, 2026. The lawsuit alleges that Erasca made false and misleading statements about its business …

ERAS main company

Sharemaestro market context Trend signal active 52 weeks +1048.8% · Next-week setup positive 63.8%

14:41 16 Jul 2026

PR Newswire Regulatory and legal Main company 🇺🇸 United States

ERAS DEADLINE: SueWallSt Reminds Erasca, Inc. Investors of Upcoming Securities Class Action Deadline

SueWallSt is notifying investors of a securities class action lawsuit filed against Erasca, Inc. (NASDAQ: ERAS) for alleged false and misleading statements made between January 14, 2025, and April 26, 2026. The lawsuit claims Erasca's preclinical comparisons of its lead drug candidate, ERAS-0015, to …

ERAS main company

Sharemaestro market context Trend signal active 52 weeks +1048.8% · Next-week setup positive 63.8%

13:41 16 Jul 2026

Investing.com Earnings Main company 🇺🇸 United States

Peraso publishes white paper on 60 GHz tech for drone security

Peraso Inc. has published a white paper detailing the strategic advantages of 60 GHz millimeter-wave technology for drone communications, addressing challenges faced by unmanned aerial systems. The technology focuses on secure, stealthy, and high-capacity communications through features like adaptive beamforming and anti-jamming capabilities. Despite …

PRSO main company

Sharemaestro market context Price below Trend Line 52 weeks -17.8% · Next-week setup negative 43.2%

13:41 16 Jul 2026

Stock Titan Market update Main company 🇺🇸 United States

Peraso Explores How 60 GHz Could Help Drones Resist Jamming

Peraso (NASDAQ: PRSO) has published a white paper detailing how its 60 GHz millimeter-wave technology can enhance drone communications, making them more secure and resistant to jamming. The paper, titled "The Strategic Advantages of 60 GHz Millimeter-Wave Technology in Drone Communications," explains how adaptive …

PRSO main company

Sharemaestro market context Price below Trend Line 52 weeks -17.8% · Next-week setup negative 43.2%

13:41 16 Jul 2026

The Joplin Globe Market update Main company 🇺🇸 United States

Peraso Releases White Paper on 60 GHz mmWave Technology for Advanced Drone Communications

Peraso Inc., a leader in 60 GHz wireless technology, has published a new white paper titled "The Strategic Advantages of 60 GHz Millimeter-Wave Technology in Drone Communications." The paper highlights how 60 GHz mmWave technology can provide secure, high-capacity, and jam-resistant wireless communications for …

PRSO main company

Sharemaestro market context Price below Trend Line 52 weeks -17.8% · Next-week setup negative 43.2%

11:42 16 Jul 2026

Sahm Market update Main company 🇺🇸 United States

Is Erasca (ERAS) Stock Trading At A Premium After New Trial Data?

Erasca (ERAS) stock has seen a significant 12.8x return over the past year, leading to questions about its current valuation. Despite updated preliminary Phase 1 data and plans for registration-enabling trials, Erasca scores poorly on valuation checks, trading at a P/B ratio of 15.4x …

ERAS main company

Sharemaestro market context Trend signal active 52 weeks +1048.8% · Next-week setup positive 63.8%

02:41 16 Jul 2026

NewMediaWire Regulatory and legal Main company 🇺🇸 United States

Kaplan Fox & Kilsheimer LLP Alerts Erasca, Inc. (NASDAQ: ERAS) Investors to a Securities Class Action Deadline on August 10, 2026

Kaplan Fox & Kilsheimer LLP has announced a securities class action lawsuit against Erasca, Inc. (NASDAQ: ERAS) with a lead plaintiff deadline of August 10, 2026. The lawsuit, filed on behalf of investors who purchased Erasca securities between January 14, 2025, and April 26, …

ERAS main company

Sharemaestro market context Trend signal active 52 weeks +1048.8% · Next-week setup positive 63.8%

21:40 15 Jul 2026

Investing.com Market update Main company 🇺🇸 United States

Erasca closes $632.5 million public stock offering

Erasca Inc. (NASDAQ:ERAS), a precision oncology company, announced the closure of its public offering, raising approximately $632.5 million from the sale of over 36 million common shares at $17.50 each. The proceeds will fund research and development for its product candidates and general corporate …

ERAS main company

Sharemaestro market context Trend signal active 52 weeks +1048.8% · Next-week setup positive 63.8%

20:41 15 Jul 2026

Stock Titan Earnings Main company 🇺🇸 United States

Erasca intends to use offering proceeds for oncology drug research

Erasca has closed its upsized public offering of 36,142,857 common shares, including the full exercise of the underwriters' option, raising approximately $632.5 million in gross proceeds. The company, focused on precision oncology, plans to allocate these funds towards research and development of its product …

ERAS main company

Sharemaestro market context Trend signal active 52 weeks +1048.8% · Next-week setup positive 63.8%

20:40 15 Jul 2026

Moomoo Market update Main company 🇺🇸 United States

Press Release: Erasca Announces Closing of Upsized Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares

Erasca has announced the closing of its upsized public offering of 33,350,000 shares of its common stock, which includes the full exercise of the underwriters' option to purchase additional shares. The offering generated gross proceeds of approximately $100.1 million before deducting underwriting discounts and …

ERAS main company

Sharemaestro market context Trend signal active 52 weeks +1048.8% · Next-week setup positive 63.8%

11:07 15 Jul 2026

PR Newswire Regulatory and legal Main company 🇺🇸 United States

ERAS Shareholder Alert: Erasca, Inc. Securities Class Action Lawsuit - Investors With Losses May Contact Levi & Korsinsky

Levi & Korsinsky, LLP has filed a securities class action lawsuit against Erasca, Inc. (NASDAQ: ERAS) on behalf of investors who purchased shares between January 14, 2025, and April 26, 2026. The lawsuit alleges that Erasca raised $258.8 million through a shelf registration statement …

ERAS main company

Sharemaestro market context Trend signal active 52 weeks +1048.8% · Next-week setup positive 63.8%

05:40 15 Jul 2026

TradingView Analyst action Main company 🇺🇸 United States

Erasca, Inc. Stock 12‑Month Price Target Raised to $21.09, Implies 18% Upside

Analysts have raised the 12-month average price target for Erasca, Inc. (ERAS) stock to $21.45, up from $21.27, suggesting a 20% potential upside from its July 13 closing price. The consensus rating among 11 analysts remains "Buy," with 9 analysts recommending a Buy and …

ERAS main company

Sharemaestro market context Trend signal active 52 weeks +1048.8% · Next-week setup positive 63.8%

05:15 15 Jul 2026

Investing.com Canada Market update Main company 🇺🇸 United States

Form 424B5 Erasca Inc For: 14 July By Investing.com

This article announces the filing of Form 424B5 by Erasca Inc. on July 14, as reported by Investing.com. It is a brief, straightforward notification of a regulatory filing, providing no further details within the article text itself beyond the company name and date of …

ERAS main company

Sharemaestro market context Trend signal active 52 weeks +1048.8% · Next-week setup positive 63.8%

234 matching headlines